← FDA DRUG APPROVALS

FDA ANDA · ANDA086711

BETA-2

Sponsor: NEPHRON

APPLICATION
ANDA086711
TYPE
ANDA
ORIGINAL APPROVAL
1981-03-30
LATEST ACTION
1997-10-27
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

BETA-2Discontinued
ISOETHARINE HYDROCHLORIDE 1% · SOLUTION · INHALATION

Approval history

1997-10-27Manufacturing (CMC) · Supplement 4AP
1997-10-27Labeling · Supplement 5AP
1981-03-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →